FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/01/079504 [Registered on: 27/01/2025] Trial Registered Prospectively
Last Modified On: 27/01/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Clinical trial to study the effects of two drugs, levobupivcaine alone and levobupivacaine with dexmedetomidine, in patients undergoing lower limb surgery. 
Scientific Title of Study   Efficacy of 0.5 percent Levobupivicaine versus 0.5 percent Levobupivicaine with Dexmedetomidine in lower limb surgeries under spinal anaesthesia : A prospective randomized double blinded study. 
Trial Acronym  NIL  
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Rajashree Devi 
Designation  PG resident 
Affiliation  Institute of medical science and SUM hospital 
Address  Department of Anaesthesiology,Institute of Medical Sciences and SUM hospital, Bhubaneswar,Odisha

Khordha
ORISSA
751003
India 
Phone  8658676815  
Fax    
Email  drrajashree01@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Swarna Banerjee 
Designation  Professor 
Affiliation  IMS AND SUM Hospital 
Address  Dept of Anaesthesiology IMS & SUM Hospital Kalinganagar Bhubaneswar

Khordha
ORISSA
751003
India 
Phone  9437341397  
Fax    
Email  swarnabanerjee@soa.ac.in  
 
Details of Contact Person
Public Query
 
Name  Rajashree Devi 
Designation  PG resident  
Affiliation  Institute of medical science and SUM hospital 
Address  Department of Anaesthesiology,Institute of Medical Sciences and SUM hospital, Bhubaneswar,Odisha

Khordha
ORISSA
751003
India 
Phone  8658676815  
Fax    
Email  drrajashree01@gmail.com  
 
Source of Monetary or Material Support  
IMS & SUM hospital Siksha O Anusandhan University Bhubaneswar 751003 Odisha India 
 
Primary Sponsor  
Name  IMS AND SUM HOSPITAL  
Address  Dept of Anaesthesiology, IMS and SUM Hospital, SOA University, Bhubaneswar 751003 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rajashree Devi  IMS & SUM Hospital, SOA university  Department of Anaesthesia, IMS & SUM Hospital, Kalinganagar, Bhubaneswar (751003)
Khordha
ORISSA 
8658676815

drrajashree01@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee,IMS & SUM Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: PCS||, (2) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  0.5% LEVOBUPIVICAINE  To see the effect of intrathecal administration of 0.5% LEVOBUPIVICAINE 3ml on onset, duration of sensory and motor block; haemodynamic alterations and duration of post operative analgesia.  
Comparator Agent  DEXMEDETOMIDINE  To see the effect of intrathecal administration of DEXMEDETOMIDINE 5mcg along with 0.5% LEVOBUPIVICAINE on onset, duration of sensory and motor block; haemodynamic alterations and duration of post operative analgesia. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients undergoing orthopaedic lower limb surgeries
Patients under ASA 1 and 2 
 
ExclusionCriteria 
Details  Patients known allergic to local anaesthetic agents
Patients having raised ICP
Patients having chronic kidney disease/acute kidney disease
Platelet and coagulation disorders
Spine deformities or skin infection at local sites
Pregnant patients
Patient having sinus bradycardia 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare the effect of intrathecal administration of Dexmedetomidine on the onset and duration of sensory and
motor block with Levobupivacaine versus Levobupivacaine alone. 
at baseline, 1 minute, 2 minutes, 3 minutes, 4 minutes, 5 minutes, 6 minutes, 7 minutes, 8 minutes, 9 minutes, 10 minutes,
25 minutes, 40 minutes, 55 minutes,70 minutes, 85 minutes, 100 minutes, 115 minutes, 130 minutes, 145 minutes, 160 minutes, 175 minutes, 190 minutes.  
 
Secondary Outcome  
Outcome  TimePoints 
To compare the haemodynamic alterations & duration of
post operative analgesia of levobupivacaine with
dexmedetomidine & levobupivacaine alone. 
at baseline, 15 minutes, 30 minutes, 45 minutes, 60 minutes, 90 minutes, 120 minutes, 150 minutes & 180 minutes 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   07/02/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This is a prospective randomised double blinded comparative study conducted at our institution.

The data to be collected are all part of routine care.

 

DATA COLLECTION METHOD USED:

considering the time and feasibility of the study, it was decided to apply convenience sampling technique to conduct the study.

Based on a priori one-tailed hypothesis, using parameters of 0.05 alpha, 95% confidence level, 0.75 moderate Effect size, 80% power and Allocation ratio 1:1, Sample size was calculated by using G Power.

 The sample size calculated was 114, which was inflated to 120 assuming 5% drop out rate, each group consisting of 60 participants.

TEST:

 Unpaired T test will be used for analysis of data (Time of onset and duration of sensory and motor block, Hemodynamic variables, Time taken to walk unaided)

Chi Square test for requirement of post op analgesia.

Data will be summarized by mean and standard deviation.

 In this study, p value of <0.05 will be considered statistically significant.

 

This prospective randomized double blinded comparative study will be conducted at our institution over a period of 18 months. In this study 120 ASA grade I and II patients between age 18 to 60 years posted for orthopedic surgeries requiring spinal anesthesia will be included. 

After taking written informed consent, patients will be randomized into two groups (n= 60) by block randomization method. All patients will be thoroughly examined preoperatively which included history, general physical examination, and checking the vital parameters of the patients such as blood pressure, pulse, respiratory rate and systemic examination, and ASA grading. The patients with a contraindication to spinal anesthesia or major neurological, cardiovascular, respiratory, renal disease, or coagulation abnormalities will be excluded.                 

All the patients will be nil by mouth fast for at least 6 hours before the procedure. All the routine monitors will be attached and the preoperative baseline readings of noninvasive blood pressure (NIBP), pulse rate (PR), and saturation (SPO2) will be noted. After securing an intravenous (IV) access using an 18-Gauge IV cannula all patients irrespective of the group they belonged to will be preloaded with Ringers lactate 10 mL/kg over 15 min.

Under all aseptic precautions, spinal anesthesia will be performed in the operating room at the L3-L4 interspace, with the patient in the sitting position with neck flexed using a 25Gauge (Quinckes Spinal Needle). The composition of intrathecal drugs depends upon the group to which the patient belongs. The drug combination to be prepared by pharmacist and will be given by an anesthesiologist who was blinded to the drug used in the study. Both the patients and the observer will be blinded to the study drug or the group. 

                   After injecting the intrathecal drug, the following parameters will be observed by an anesthesiologist who will be blinded to the type of drug given to the patient. NIBP will be noted every minute for 10 minutes and then every 5 minutes until the end of surgery. A hypotensive episode is defined as systolic blood pressure (SBP) < 90 mmHg or a decrease in SBP 20% of the baseline value. Hypotension will be managed by rapid infusion of 250 ml of Ringer lactate and 6mg incremental doses of intravenous ephedrine. Clinically relevant bradycardia is defined as HR < 50 bpm and will be managed with incremental doses of 0.3 mg intravenous atropine.  The onset of sensory block is defined as the time taken for loss of sharp sensation with the pinprick test until the T10 dermatome level after injecting the drug (TT10). The recordings will be noted every minute for the initial 10 minutes, and then every 15 minutes thereafter. The maximum height of sensory block reached will be also noted (Hmax). The time taken for regression of the block to L1 will be noted (Treg2). Motor blockade will be assessed using the modified Bromage scale (modified Bromage scale: 1 = unable to move feet or knees, 2 = able to move feet only, 3 = just able to move knees, 4 = full flexion of knees with detectable weakness of hip flexion while supine, 5 = no detectable weakness of hip flexion while supine, 6 = able to perform partial knee bend). The time taken to achieve adequate motor block (TBrom2), defined as a score of 2 on the modified Bromage scale, will be recorded by testing the motor block every minute until a score of 2 achieved.

Surgery  will  be  commenced  once  adequate  sensory  (T10)  and  motor  (modified Bromage 2) block achieved. After the surgery, the patients will be shifted to the post-anesthesia care unit and standard monitoring will be continued. The sensory level and motor blockade will be checked every 10 min. The duration of sensory loss (Tanes) will be defined as the time interval between the onset of sensory block (T10 level) to regression of the sensory block to the L1 dermatome. The duration of the motor block (TMB) will be defined as the time interval between the onset of motor block (modified Bromage scale 3) to the achievement of modified Bromage scale 6 after the surgery. Once a modified Bromage score of 0 achieved, patients will be encouraged to stand up and walk initially with support and then unaided. Post operative follow up, to know the time taken to walk unaided will be noted accordingly. Nausea, vomiting, shivering or any other side effects were followed up post operatively for 24 hours and treated upon.

Postoperative pain was assessed with the help of visual analogue scale (VAS). For post operative pain (VAS >4) injection tramadol 100 mg i.v. was given as rescue analgesia and then can be repeated four hourly if needed (maximum daily dose 400 mg/day). 

 
Close